Aksaan Arif
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Aksaan Arif has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Bibek Das
Department of Surgery and Cancer, Imperial College London, London, United Kingdom
1 shared publication - Drit Gashi
Vascular Surgery Department, Imperial College Healthcare NHS Trust, London, UK
1 shared publication - Henry Douglas Robb
Department of Surgery and Cancer, Imperial College London, London, UK
1 shared publication - Hutan Ashrafian
Institute of Global Health Innovation, Imperial College London, London, UK
1 shared publication - Khalid Al-Yaqout
Jaber Al Ahmad Hospital Kuwait City Kuwait
1 shared publication - Krzysztof Sosnowski
School of Clinical Medicine, University of Cambridge, Cambridge, UK
1 shared publication
Latest Publications
- Open Access
- 27 August 2026
- Published by Wolters Kluwer Health in International Journal of Surgery
Part 2: the challenges and limitations of artificial intelligence in surgery
The integration of artificial intelligence (AI) into surgical practice is advancing rapidly, offering the potential to enhance clinical decision-making, minimize complications, and optimize screening processes. However, the widespread adoption of AI faces significant challenges. High implementation costs, algorithmic bias, and the risk of over-reliance on AI systems present notable barriers. Additionally, regulatory frameworks struggle to keep pace with the rapidly evolving nature of AI, raising concerns about safety and ethical oversight. Potential solutions include developing high-quality labeled datasets, creating standardized validation pathways, strengthening regulatory frameworks, and fostering ethical guidelines to ensure safe, effective, and responsible adoption of AI in modern surgical practice. By examining the ethical, financial, and regulatory barriers, this review provides a comprehensive and focused synthesis of the critical challenges hindering the incorporation of AI into surgery and begins to outline possible pathways toward safer and more effective implementation.
- 27 August 2026
- Published by Wolters Kluwer Health in International Journal of Surgery
Open AccessPart 2: the challenges and limitations of artificial intelligence in surgery
The integration of artificial intelligence (AI) into surgical practice is advancing rapidly, offering the potential to enhance clinical decision-making, minimize complications, and optimize screening processes. However, the widespread adoption of AI faces significant challenges. High implementation costs, algorithmic bias, and the risk of over-reliance on AI systems present notable barriers. Additionally, regulatory frameworks struggle to keep pace with the rapidly evolving nature of AI, raising concerns about safety and ethical oversight. Potential solutions include developing high-quality labeled datasets, creating standardized validation pathways, strengthening regulatory frameworks, and fostering ethical guidelines to ensure safe, effective, and responsible adoption of AI in modern surgical practice. By examining the ethical, financial, and regulatory barriers, this review provides a comprehensive and focused synthesis of the critical challenges hindering the incorporation of AI into surgery and begins to outline possible pathways toward safer and more effective implementation.
- Open Access
- 26 February 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 111 (5) , 3159-3168
How is 3D modeling in metabolic surgery utilized and what is its clinical benefit: a systematic review and meta-analysis
Background: Three-dimensional (3D) modeling is an emerging technology in surgery, with applications in operative planning, surgical education, and patient engagement. Metabolic surgery, the most effective treatment for obesity, is increasingly prevalent leading to new complex clinical challenges. This systematic review aims to understand the use of 3D modeling in metabolic surgery and its impact on clinical outcomes. Methods: Following a registered protocol (PROSPERO: CRD42024545311), a comprehensive search using MEDLINE, Embase, and CENTRAL Cochrane Library was conducted. Eligible papers underwent screening and full-text review. A qualitative thematic analysis was performed alongside meta-analyses on available volumetric data. Results were reported as directed by the PRISMA guidelines. Results: Twenty-nine studies were included, with most at Level II evidence (n = 19, 66%). Studies focused on operative planning and surgical practice (90%, n = 26) and were subdivided into preoperative planning (14%, n = 4), postoperative diagnosis (31%, n = 9), and postoperative assessment and prediction (45%, n = 13). Only three papers addressed surgical education (10%). 3D modeling for patient education was unexplored. To assess 3D modeling’s cross-study consistency, pooled meta-analyses on preoperative and postoperative 3D gastric volumetry and abdominal circumference were performed. Average preoperative stomach volume was 794.93 mL (95% confidence interval [CI]: 518.61–1071.26 mL). Postoperative LSG and RYGB/OAGB gastric volumes were 171.71 mL (95% CI: 113.37–288.58 mL) and 35.73 mL (95% CI: 29.32–42.14 mL) respectively. Average abdominal circumference was 120.04 cm (95% CI: 100.72–139.35 cm). All volumes were consistent with published data. Conclusions: This systematic review highlighted the accuracy of 3D modeling for volumetric assessments and its developing role in surgical planning and training. However, its potential benefits in AR or 3DP models, in patient education or for answering bariatric surgical debates using 3D volumetric studies remain underutilized.
- 26 February 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 111 (5) , 3159-3168
Open AccessHow is 3D modeling in metabolic surgery utilized and what is its clinical benefit: a systematic review and meta-analysis
Background: Three-dimensional (3D) modeling is an emerging technology in surgery, with applications in operative planning, surgical education, and patient engagement. Metabolic surgery, the most effective treatment for obesity, is increasingly prevalent leading to new complex clinical challenges. This systematic review aims to understand the use of 3D modeling in metabolic surgery and its impact on clinical outcomes. Methods: Following a registered protocol (PROSPERO: CRD42024545311), a comprehensive search using MEDLINE, Embase, and CENTRAL Cochrane Library was conducted. Eligible papers underwent screening and full-text review. A qualitative thematic analysis was performed alongside meta-analyses on available volumetric data. Results were reported as directed by the PRISMA guidelines. Results: Twenty-nine studies were included, with most at Level II evidence (n = 19, 66%). Studies focused on operative planning and surgical practice (90%, n = 26) and were subdivided into preoperative planning (14%, n = 4), postoperative diagnosis (31%, n = 9), and postoperative assessment and prediction (45%, n = 13). Only three papers addressed surgical education (10%). 3D modeling for patient education was unexplored. To assess 3D modeling’s cross-study consistency, pooled meta-analyses on preoperative and postoperative 3D gastric volumetry and abdominal circumference were performed. Average preoperative stomach volume was 794.93 mL (95% confidence interval [CI]: 518.61–1071.26 mL). Postoperative LSG and RYGB/OAGB gastric volumes were 171.71 mL (95% CI: 113.37–288.58 mL) and 35.73 mL (95% CI: 29.32–42.14 mL) respectively. Average abdominal circumference was 120.04 cm (95% CI: 100.72–139.35 cm). All volumes were consistent with published data. Conclusions: This systematic review highlighted the accuracy of 3D modeling for volumetric assessments and its developing role in surgical planning and training. However, its potential benefits in AR or 3DP models, in patient education or for answering bariatric surgical debates using 3D volumetric studies remain underutilized.